Early prediction of severe acute cholecystitis using routine admission parameters: a study of 1,330 patients - Scorecard - MDSpire

Early prediction of severe acute cholecystitis using routine admission parameters: a study of 1,330 patients

  • By

  • Alparslan Ertenlice

  • Hikmet Pehlevan Özel

  • Zeynep Nur Yurdakul

  • Mehmet Sefa Çamöz

  • Gözde İğdeci Tut

  • Şule Bal

  • İbrahim Kılınç

  • Sadettin Er

  • June 23, 2026

  • 0 min

Share

Clinical Scorecard: Predicting Severe Acute Cholecystitis Early Through Standard Admission Metrics: Analysis of 1,330 Cases

At a Glance

CategoryDetail
ConditionAcute Cholecystitis
Key MechanismsAssessment of disease severity using clinical findings, laboratory parameters, and organ dysfunction criteria.
Target PopulationAdults over the age of 18 diagnosed with acute cholecystitis.
Care SettingTertiary referral center

Key Highlights

  • Acute cholecystitis is a common surgical emergency with varying prevalence.
  • Tokyo Guidelines 2018 (TG18) classify severity into mild, moderate, and severe.
  • Severe cases are associated with increased complications and prolonged hospital stays.
  • Predictive models using demographic and laboratory parameters are needed for early risk stratification.
  • Objective biomarkers can aid in predicting disease severity and clinical outcomes.

Guideline-Based Recommendations

Diagnosis

  • Utilize TG18 diagnostic and staging criteria for acute cholecystitis.

Management

  • Cholecystectomy is the primary treatment; consider conservative management for high-risk patients.

Monitoring & Follow-up

  • Monitor for complications such as perforation, abscess, and sepsis.

Risks

  • Increased morbidity and mortality rates associated with severe acute cholecystitis.

Patient & Prescribing Data

Patients diagnosed with acute cholecystitis, excluding those with active infections or malignancies.

Alternative strategies include conservative management, percutaneous cholecystostomy, and elective cholecystectomy.

Clinical Best Practices

  • Incorporate objective laboratory biomarkers for early assessment of disease severity.
  • Evaluate clinical factors carefully in severe acute cholecystitis cases.

Related Resources & Content

Original Source(s)

Related Content